Silexion Therapeutics Ltd. (SLXNW) Financials
SLXNW Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 4.2 million | 4.2 million |
| March 31, 2026 | 4.6 million | 4.3 million |
| Dec. 31, 2025 | 7.2 million | 4.6 million |
| Sept. 30, 2025 | 11.6 million | 4.6 million |
SLXNW Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -2.9 million | 197000 |
| March 31, 2026 | -3.6 million | 345000 |
| Dec. 31, 2025 | -3.0 million | 38000 |
| Sept. 30, 2025 | -2.8 million | 38000 |
SLXNW Net Income
No data available :(
SLXNW Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 2.2 million | - | 425000 |
| March 31, 2026 | 2.4 million | 251000 | 436000 |
| Dec. 31, 2025 | 6.0 million | 286000 | 468000 |
| Sept. 30, 2025 | 9.2 million | 311000 | 485000 |
SLXNW Shares Outstanding
SLXNW Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 2.2 million | 1.5 million | - |
| March 31, 2026 | - | 1.4 million | 1.4 million | - |
| Dec. 31, 2025 | 2000 | 3.4 million | 1.0 million | - |
| Sept. 30, 2025 | - | 2.2 million | 1.1 million | - |
SLXNW Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | 3000 |
| March 31, 2026 | - | 2000 |
| Dec. 31, 2025 | - | 3000 |
| Sept. 30, 2025 | - | 4000 |
SLXNW
Price: $0.02
52 week price:
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 11219